Filing Details
- Accession Number:
- 0001104659-18-017864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-15 16:15:31
- Reporting Period:
- 2018-03-13
- Accepted Time:
- 2018-03-15 16:15:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611148 | B. Jason Shandell | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | President And General Counsel | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-13 | 300 | $11.79 | 217,248 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-13 | 300 | $20.45 | 216,948 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-03-14 | 400 | $11.79 | 217,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-14 | 400 | $20.45 | 216,948 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-03-13 | 300 | $0.00 | 300 | $11.79 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-03-14 | 400 | $0.00 | 400 | $11.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,700 | 2020-09-28 | No | 4 | M | Direct | |
| 5,300 | 2020-09-28 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2017.
- Shares subject to the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
